Tuesday, Jul 28, 2026

"nejm"

Novo Nordisk’s obesity drug can reduce heart problem risk by 20%: Study

The study conducted by the Danish pharma giant showed that the risk reductions were evident soon after initiation, suggesting an effect of semaglutide 2.4 mg beyond weight loss alone.

Latest News

Retired Delhi Police to hold dharna over violence during ‘Chalo Sansad’ protest

7 mins ago
Respect, not compulsion: AIMIM’s Waris Pathan on ‘Vande Mataram’

22 mins ago
Kerala launches 24×7 highway enforcement in six zones to curb speeding, accidents

38 mins ago
Opposition stalls Rajya Sabha over NEET agitation; MSME Bill introduced

52 mins ago
Kerala seeks relaxation in Tamil Nadu’s stone transport restrictions

1 hour ago
Odisha youth arrested at Charlapalli Railway Station for alleged marijuana smuggling

1 hour ago
Two dead after suspected drowning in Yamuna; rescue operation suspended

1 hour ago
Pegasystems expands University Academic Programme with three new partners in India

1 hour ago